Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy

Prof. Scott T. Tagawa

Medical Director, Genitourinary Oncology Research Program, Weill Cornell Medical College, New York, USA

Webcast

Symposium: Emerging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC); Understanding combination anti-androgen therapy and androgen deprivation therapy

ORC Supporters & Partners

Wanna Support ORC ?

Sponsorship Inquiries ?

Subscribe to our email alerts

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.